P. Spirito

C. Autore, B. Musumeci, P. Spirito, 2011, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

Apical hypertrophic cardiomyopathy or left ventricular non-compaction? A difficult differential diagnosis.

C. Autore, P. Spirito, 2007, European heart journal.

Case for Earlier Surgical Myectomy in Patients With Obstructive Hypertrophic Cardiomyopathy.

B. Maron, M. Maron, P. Spirito, 2018, Circulation.

Occurrence and significance of progressive left ventricular wall thinning and relative cavity dilatation in hypertrophic cardiomyopathy.

R. Bonow, B. Maron, S. Epstein, 1987, The American journal of cardiology.

Atrial Fibrillation Precipitating Sustained Ventricular Tachycardia in Hypertrophic Cardiomyopathy

G. Boriani, M. Biffi, A. Branzi, 2002, Journal of cardiovascular electrophysiology.

Higher pregnancy rates following treatment of cervical factor with intrauterine insemination without superovulation versus intercourse: the importance of a well-timed postcoital test for infertility.

P. Spirito, J. Check, Jerome H. Check, 1995, Archives of andrology.

High risk for sudden death identified by electrocardiographic loop recording in a patient with hypertrophic cardiomyopathy without major risk factors.

C. Autore, M. Musumeci, P. Spirito, 2011, The American journal of cardiology.

Cardiac disease in young trained athletes. Insights into methods for distinguishing athlete's heart from structural heart disease, with particular emphasis on hypertrophic cardiomyopathy.

B. Maron, A. Pelliccia, P. Spirito, 1995, Circulation.

Targeted next-generation sequencing helps to decipher the genetic and phenotypic heterogeneity of hypertrophic cardiomyopathy

C. Autore, C. Rapezzi, C. Forleo, 2016, International journal of molecular medicine.

Prognostic Value of Quantitative Contrast-Enhanced Cardiovascular Magnetic Resonance for the Evaluation of Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy

E. Cook, M. Pencina, W. Manning, 2014, Circulation.

Noninvasive assessment of left ventricular diastolic function: comparative analysis of Doppler echocardiographic and radionuclide angiographic techniques.

R. Bonow, B. Maron, P. Spirito, 1986, Journal of the American College of Cardiology.

Left atrial appendage function assessed by transesophageal echocardiography before and on the day after elective cardioversion for nonvalvular atrial fibrillation.

G. Lupi, C. Vecchio, P. Spirito, 1998, The American journal of cardiology.

Relation between extent of left ventricular hypertrophy and diastolic filling abnormalities in hypertrophic cardiomyopathy.

B. Maron, P. Spirito, Barry J. Maron, 1990, Journal of the American College of Cardiology.

Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population.

M. Z. Berisso, F. Chiarella, P Spirito, 1989, The New England journal of medicine.

Influence of aging on Doppler echocardiographic indices of left ventricular diastolic function.

B. Maron, P. Spirito, 1988, British heart journal.

Noninvasive assessment of left ventricular diastolic function by pulsed Doppler echocardiography in patients with hypertrophic cardiomyopathy.

R. Bonow, B. Maron, P. Spirito, 1987, Journal of the American College of Cardiology.

Noninvasive assessment of left ventricular diastolic function: comparative analysis of pulsed Doppler ultrasound and digitized M-mode echocardiography.

B. Maron, F. Chiarella, C. Vecchio, 1986, The American journal of cardiology.

Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy.

J. Seidman, H. Watkins, C. Seidman, 1995, The New England journal of medicine.

Clinical features of hypertrophic cardiomyopathy caused by mutation of a "hot spot" in the alpha-tropomyosin gene.

J. Seidman, B. Maron, H. Watkins, 1997, Journal of the American College of Cardiology.

Glycogen storage diseases presenting as hypertrophic cardiomyopathy.

J. Seidman, J. Saul, B. Maron, 2005, The New England journal of medicine.

Approach to hypertrophic cardiomyopathy

C. Autore, P. Spirito, 2004, Current treatment options in cardiovascular medicine.

The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes.

M. Proschan, B. Maron, A. Pelliccia, 1991, The New England journal of medicine.

Relation of electrocardiographic abnormalities and patterns of left ventricular hypertrophy identified by 2-dimensional echocardiography in patients with hypertrophic cardiomyopathy.

B. Maron, E. Ciró, P. Spirito, 1983, The American journal of cardiology.

Systolic anterior motion of the posterior mitral leaflet: a previously unrecognized cause of dynamic subaortic obstruction in patients with hypertrophic cardiomyopathy.

W. Roberts, B. Maron, B. Waller, 1983, Circulation.

Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy.

B. Maron, I. Olivotto, F. Cecchi, 2002, Journal of the American College of Cardiology.

Approach to the Initial and Follow-Up Visits

C. Autore, P. Spirito, 2015 .

Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine.

Barry J Maron, Iacopo Olivotto, Christopher Semsarian, 2014, Journal of the American College of Cardiology.

Management of hypertrophic cardiomyopathy

C. Autore, Paolo Spirito, P. Spirito, 2006, BMJ : British Medical Journal.

The prognostic importance of left ventricular outflow obstruction in hypertrophic cardiomyopathy varies in relation to the severity of symptoms.

C. Autore, P. Bruzzi, P. Spirito, 2005, Journal of the American College of Cardiology.

Prevention of Sudden Death in Hypertrophic Cardiomyopathy: But Which Defibrillator for Which Patient?

G. Boriani, B. Maron, W. Shen, 2004, Circulation.

American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice G

Barry J Maron, Folkert J Ten Cate, Christine E Seidman, 2003, Journal of the American College of Cardiology.

American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice G

C. Tracy, S. Priori, S. Kaul, 2003, European heart journal.

Hypertrophic Cardiomyopathy Clinical Profile of Stroke in 900 Patients With Hypertrophic Cardiomyopathy

B. Maron, I. Olivotto, F. Cecchi, 2001 .

Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population.

B. Maron, I. Olivotto, F. Cecchi, 2000, Circulation.

A mutant tropomyosin that causes hypertrophic cardiomyopathy is expressed in vivo and associated with an increased calcium sensitivity.

B. Maron, H. Watkins, C. Reggiani, 1998, Circulation research.

MYOCARDIAL INFARCTION Prognostic significance and natural history of left ventricular thrombi in patients with acute anterior myocardial infarction : a two-dimensional echocardiographic study

S. Domenicucci, F. Chiarella, C. Vecchio, 2022 .

Acidic fibroblast growth factor in the developing rat embryo

V. Ferrans, S. Epstein, W. Casscells, 1991, The Journal of cell biology.

Infective endocarditis in hypertrophic cardiomyopathy: prevalence, incidence, and indications for antibiotic prophylaxis.

C. Autore, P. Bruzzi, C. Rapezzi, 1999, Circulation.

Severe functional limitation in patients with hypertrophic cardiomyopathy and only mild localized left ventricular hypertrophy.

R. Bonow, B. Maron, S. Epstein, 1986, Journal of the American College of Cardiology.

Diastolic abnormalities in patients with hypertrophic cardiomyopathy: relation to magnitude of left ventricular hypertrophy.

B. Maron, M. Pozzoli, R. Tramarin, 1985, Circulation.

Experience from clinical genetics in hypertrophic cardiomyopathy: proposal for new diagnostic criteria in adult members of affected families.

W. Mckenna, M. Komajda, M. Desnos, 1997, Heart.

Experience fromclinical genetics inhypertrophic cardiomyopathy: proposal fornewdiagnostic criteria inadult membersofaffected families

M. Komajda, M. Desnos, O. Dubourg, 1997 .

Impact of patient selection biases on the perception of hypertrophic cardiomyopathy and its natural history.

B. Maron, P. Spirito, 1993, The American journal of cardiology.

Echocardiographic Assessment of Mitral Valve Size in Obstructive Hypertrophic Cardiomyopathy Anatomic Validation From Mitral Valve Specimen

M A Proschan, M. Proschan, W. Roberts, 1993, Circulation.

Relation between extent of left ventricular hypertrophy and occurrence of ventricular tachycardia in hypertrophic cardiomyopathy.

B. Maron, R. Watson, P. Spirito, 1987, The American journal of cardiology.

Absence of progression of left ventricular hypertrophy in adult patients with hypertrophic cardiomyopathy.

B. Maron, P. Spirito, 1987, Journal of the American College of Cardiology.

Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.

M. Link, G. Boriani, J. Daubert, 2007, JAMA.

Relation between extent of left ventricular hypertrophy and occurrence of sudden cardiac death in hypertrophic cardiomyopathy.

B. Maron, P. Spirito, 1990, Journal of the American College of Cardiology.

Risk stratification and prevention of sudden death in hypertrophic cardiomyopathy

C. Autore, G. Quarta, P. Spirito, 2007, Current treatment options in cardiovascular medicine.

Relation between extent of left ventricular hypertrophy and age in hypertrophic cardiomyopathy.

B. Maron, P. Spirito, 1989, Journal of the American College of Cardiology.

Prevalence, Clinical Profile, and Significance of Left Ventricular Remodeling in the End-Stage Phase of Hypertrophic Cardiomyopathy

W. Manning, B. Maron, M. Maron, 2006, Circulation.

Implantable Defibrillators and Prevention of Sudden Death in Hypertrophic Cardiomyopathy

B. Maron, P. Spirito, 2008, Journal of cardiovascular electrophysiology.

Risk Stratification and Prevention Risk Stratification and Prevention of Sudden Death in Hypertrophic of Sudden Death in Hypertrophic CardiomyopathyAutore, MD

G. Quarta, P. Spirito, 2007 .

Extreme Left Vetricular Hypertrophy: An Indicator of Increased Risk of Sudden Death in Hypertrophic Cardiomyopathy

C. Autore, P. Spirito, P. Bernabò, 2004 .

Relation of extreme left ventricular hypertrophy to age in hypertrophic cardiomyopathy.

B. Maron, P. Spirito, P. Bernabò, 2003, The American journal of cardiology.

The challenge of diagnosing hypertrophic cardiomyopathy in patients of African descent

P. Ferrazzi, P. Spirito, 2016, Heart.

Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy Prognostic Value of Quantitative Contrast-Enhanced Cardiovascular Magnetic Resonance

E. Cook, M. Pencina, W. Manning, 2014 .

Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy.

M. Link, E. Ashley, G. Boriani, 2013, Journal of the American College of Cardiology.

Ventricular fibrillation during sleep in an adolescent with hypertrophic cardiomyopathy: the difficulty of risk stratification and the power of the cardioverter-defibrillator.

G. Boriani, M. Biffi, A. Branzi, 2004, International journal of cardiology.

Prognosis of Asymptomatic Patients With Hypertrophic Cardiomyopathy and Nonsustained Ventricular Tachycardia

C. Autore, P. Bruzzi, A. Branzi, 1994, Circulation.

Heart transplantation in hypertrophic cardiomyopathy.

G. Boriani, E. Arbustini, A. Branzi, 2008, American Journal of Cardiology.

Prevalence of hypertrophic cardiomyopathy in a population-based sample of American Indians aged 51 to 77 years (the Strong Heart Study).

B. Maron, P. Okin, R. Devereux, 2004, The American journal of cardiology.

Implications of left ventricular remodeling in hypertrophic cardiomyopathy.

B. Maron, P. Spirito, 1998, The American journal of cardiology.

Syncope and Risk of Sudden Death in Hypertrophic Cardiomyopathy

C. Autore, B. Maron, P. Bruzzi, 2009, Circulation.

Management of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review.

M. Desai, J. Towbin, B. Maron, 2022, Journal of the American College of Cardiology.

Clinical Course and Quality of Life in High-Risk Patients With Hypertrophic Cardiomyopathy and Implantable Cardioverter-Defibrillators

G. Boriani, C. Autore, B. Maron, 2018, Circulation. Arrhythmia and electrophysiology.

Reply: Obstructive sleep apnea and hypertrophic cardiomyopathy: obiter dictum or more?

S. Ommen, B. Maron, M. Maron, 2014, Journal of the American College of Cardiology.

Significance of Late Gadolinium Enhancement at Right Ventricular Attachment to Ventricular Septum in Patients With Hypertrophic Cardiomyopathy.

W. Manning, C. Autore, W. Roberts, 2015, The American journal of cardiology.

Usefulness of delayed enhancement by magnetic resonance imaging in hypertrophic cardiomyopathy as a marker of disease and its severity.

V. Positano, G. Aquaro, M. Lombardi, 2010, The American journal of cardiology.

Management of hypertrophic cardiomyopathy.

W. Mckenna, B. Maron, C. Seidman, 1993 .

Why we need more septal myectomy surgeons: An emerging recognition

N. Smedira, M. Desai, S. Ommen, 2017, The Journal of thoracic and cardiovascular surgery.

Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy

Alessandro Pingitore, Massimo Lombardi, Vincenzo Positano, 2010, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

Relation Between Extent of Left Ventricular Hypertrophy Hypertrophic Cardiomyopathy and Age in

B. Maron, P. Spirito, 2016 .

Reproducibility of Doppler echocardiographic measurements of left ventricular diastolic function.

B. Maron, P. Spirito, J. Merrill, 1988, European heart journal.

Transaortic Chordal Cutting: Mitral Valve Repair for Obstructive Hypertrophic Cardiomyopathy With Mild Septal Hypertrophy.

M. Senni, B. Maron, P. Bruzzi, 2015, Journal of the American College of Cardiology.

Usefulness of Doppler echocardiographic assessment of diastolic filling in distinguishing “athlete's heart” from hypertrophic cardiomyopathy

B. Maron, A. Pelliccia, Jannet F. Lewis, 1992, British heart journal.

Ventricular tachycardia/fibrillation early after defibrillator implantation in patients with hypertrophic cardiomyopathy is explained by a high-risk subgroup of patients.

M. Link, G. Boriani, B. Maron, 2013, Heart rhythm.

Researchanalysis of late gadolinium enhancement in hypertrophic cardiomyopathy

V. Positano, G. Aquaro, M. Lombardi, 2010 .

Saving More Lives.

P. Spirito, 2017, Journal of the American College of Cardiology.

A of the diagnostic criteria for hypertrophic cardiomyopathy: a major clinical need unmet by current tools

A. Millaire, P. Spirito, 2003 .

Prognostic implications of novel beta cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy.

S. Solomon, J. Seidman, W. Mckenna, 1994, The Journal of clinical investigation.

The management of hypertrophic cardiomyopathy.

W. Mckenna, B. Maron, C. Seidman, 1997, The New England journal of medicine.

Management of hypertrophic cardiomyopathy.

M. Desai, J. Towbin, B. Maron, 1993, Heart disease and stroke : a journal for primary care physicians.

A de novo mutation in alpha-tropomyosin that causes hypertrophic cardiomyopathy.

J. Seidman, H. Watkins, C. Seidman, 1995, Circulation.

Heart transplantation in hypertrophic cardiomyopathy.

G. Boriani, E. Arbustini, A. Branzi, 2008, The American journal of cardiology.

Extensive myocardial fibrosis in a patient with hypertrophic cardiomyopathy and ventricular tachycardia without traditional high-risk features.

R. Bonamini, A. Chiribiri, P. Spirito, 2009, Circulation. Cardiovascular imaging.

Apical hypertrophic cardiomyopathy or left ventricular non-compaction? A difficult differential diagnosis.

C. Autore, P. Spirito, 2007, European heart journal.

Clinical outcome and phenotypic expression in LAMP2 cardiomyopathy.

J. Seidman, J. Saul, W. Roberts, 2009, JAMA.

A new index for the diagnosis of outflow obstruction in hypertrophic cardiomyopathy: is it accurate? and if so, is it useful?

P. Spirito, L. Boni, 2023, European heart journal. Cardiovascular Imaging.

The prognostic importance of left ventricular outflow obstruction in hypertrophic cardiomyopathy varies in relation to the severity of symptoms.

C. Autore, P. Bruzzi, P. Spirito, 2005, Journal of the American College of Cardiology.

Risk stratification and prevention of sudden death in hypertrophic cardiomyopathy

C. Autore, G. Quarta, P. Spirito, 2007, Current Treatment Options in Cardiovascular Medicine.

PROGNOSTIC UTILITY OF CONTRAST-ENHANCED CARDIOVASCULAR MAGNETIC RESONANCE IN HYPERTROPHIC CARDIOMYOPATHY: AN INTERNATIONAL MULTICENTER STUDY

E. Cook, W. Manning, C. Autore, 2012 .

Right atrial thrombus detected by two-dimensional echocardiography after acute pulmonary embolism.

F. Chiarella, C. Vecchio, P. Spirito, 1984, The American journal of cardiology.

Transaortic Chordal Cutting: Mitral Valve Repair for Obstructive Hypertrophic Cardiomyopathy With Mild Septal Hypertrophy.

M. Senni, B. Maron, P. Bruzzi, 2015, Journal of the American College of Cardiology.

The dawn of a better day for patients with hypertrophic cardiomyopathy.

P. Spirito, 2015, Journal of the American College of Cardiology.

Severe left ventricular wall thinning and extensive fibrosis without evolution to end stage disease in a patient with hypertrophic cardiomyopathy.

C. Autore, M. Lombardi, G. Quarta, 2009, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.